AI Article Synopsis
- The report analyzed ocular and vision disease impacts among U.S. Armed Forces service members in 2018, focusing on the healthcare burden from various conditions.
- Over half (51.1%) of medical encounters were due to refractive errors, with myopia being the most common condition treated.
- Conjunctival disorders and corneal disorders followed behind, while optic nerve conditions caused a significant portion (30.1%) of hospital bed days.
Article Abstract
The current report used an ocular and vision disease classification system and several healthcare burden measures to quantify the impacts of various ocular and vision-related illnesses and injuries among active component service members of the U.S. Armed Forces during 2018. More service members received care for refractive error and related disorders than any other ocular and vision-related major category; this category accounted for slightly more than one-half (51.1%) of all ocular and vision-related medical encounters. Conjunctival disorders accounted for the next highest percentage of total medical encounters (13.3%) followed by corneal disorders (7.5%). The 3 specific ocular and vision-related conditions that accounted for the most medical encounters (i.e., myopia, astigmatism, and acute conjunctivitis) accounted for almost one-half (47.7%) of all ocular and vision-related medical encounters overall. In general, the conditions that accounted for the most medical encounters were predominantly refractive error and related disorders and conjunctival disorders. More active component service members received medical care for myopia than for any other specific condition. Optic nerve conditions and visual discomfort/disturbances accounted for more than onequarter (30.1%) of all ocular and vision-related hospital bed days.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Improvement in vision-related quality-of-life using the NEI-VFQ-9 over 1-year in the Manhattan Vision Screening and Follow-up Study (NYC-SIGHT).
Graefes Arch Clin Exp Ophthalmol
January 2025
Department of Ophthalmology, Columbia University, Vagelos College of Physicians and Surgeons, 630 W 168th Street, New York, NY, 10032, USA.
Purpose: To examine the nine-item National Eye Institute Vision Function Questionnaire (NEI-VFQ-9) scores at baseline and 12 months in participants enrolled in the Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) and determine factors associated with improvements in vision-related quality-of-life (VRQOL).
Methods: Retrospective review of NEI-VFQ-9 scores at baseline and 12-month follow-up in a community-based eye health screening study conducted in Upper Manhattan, New York. Participants were age ≥ 40 years and older, living independently in public/affordable housing developments and able to provide informed consent.
Intense Pulsed Light in the Treatment of Dry Eye and Meibomian Gland Dysfunction in Patients With Chronic Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Cornea
January 2025
Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Purpose: To evaluate the efficacy and safety of intense pulsed light (IPL) combined with meibomian gland expression (MGX) for the treatment of dry eye disease and meibomian gland dysfunction associated with chronic Stevens-Johnson syndrome and toxic epidermal necrolysis.
Methods: This prospective noncomparative interventional study included 29 patients (58 eyes) who underwent 3 sessions of IPL and MGX at 2-week intervals. Subjective symptoms (ocular surface disease index score) and objective dry eye tests: matrix metalloproteinase 9, tear meniscus height, bulbar redness score, tear film lipid layer thickness (LLT), Schirmer I test, conjunctival and corneal staining, meibomian gland loss, MGX score [meibomian gland score (MGS)], and tear break-up time were assessed at the baseline and after 4, 8, and 12 weeks.
Lactobacillaceae-mediated eye-brain-gut axis regulates high myopia-related anxiety: from the perspective of predictive, preventive, and personalized medicine.
EPMA J
December 2024
National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, 270 Xueyuan Xi Rd, Wenzhou, Zhejiang 325027 China.
Article Synopsis
- - High myopia is increasingly linked to blindness and can negatively affect mental health by influencing the brain and gut microbiome, making it important for understanding overall health connections.
- - The study hypothesized that visual issues from high myopia might disrupt gut health, potentially leading to anxiety and depression, testing this through genetic analysis in large cohorts.
- - Results indicated a significant genetic link between high myopia and anxiety, with part of this effect mediated by gut microbiome changes, suggesting a need for new approaches in preventive medicine.
Evaluation of the clinical efficacy of modified LSC transplantation plus BCL implantation in the treatment of pterygium.
BMC Ophthalmol
December 2024
Department of Ophthalmology, Ziyang Central Hospital, Sichuan, 641300, China.
Objective: To explore the clinical efficacy of modified limbal stem cell transplantation(Modified LSC transplantation) and bandage contact lens(BCL) implantation in pterygium surgery.
Methods: A total of 479 patients with primary pterygium who were admitted to our hospital from March 2019 to March 2023 were randomly divided into three groups: the normal group (Group A: 89 patients), the control group (Group B: 195 patients), and the modified group (Group C: 195 patients). Each group received different intervention measures.
Transorbital Alternating Current Stimulation in a Double-Masked Randomized Clinical Trial: Visual Functional Effect and Quality of Life.
Ophthalmol Sci
September 2024
Glaucoma Service, Wills Eye Hospital, Philadelphia, Pennsylvania.
Purpose: To determine the efficacy and safety of repetitive transorbital alternating current stimulation (rtACS) treatment by assessing vision-related quality of life and visual function outcome in subjects treated with rtACS versus sham-control.
Study Design: Double masked, randomized, sham-controlled clinical trial (NCT03188042).
Subjects: Sixteen subjects with moderate-to-advanced glaucoma (visual field [VF] mean deviation [MD] ≤-6.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!